These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37005685)

  • 1. Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma.
    Peng Z; Wu Y; Wang J; Gu S; Wang Y; Xue B; Fu P; Xiang W
    Stem Cell Res Ther; 2023 Apr; 14(1):56. PubMed ID: 37005685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma.
    Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X
    J Inflamm Res; 2022; 15():17-32. PubMed ID: 35018108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma.
    Zhao Z; Zheng B; Zheng J; Zhang Y; Jiang C; Nie C; Jiang X; Yao D; Zhao H
    J Mol Neurosci; 2023 Aug; 73(7-8):608-627. PubMed ID: 37488455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
    Zhou J; Guo H; Liu L; Jin Z; Zhang W; Tang T
    J Cell Mol Med; 2023 Dec; 27(23):3851-3863. PubMed ID: 37775993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The study of an anoikis-related signature to predict glioma prognosis and immune infiltration.
    Zhang D; Wang Y; Zhou H; Han X; Hou L; Lv Z; Xue X
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12659-12676. PubMed ID: 37450027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 9. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
    Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
    Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
    Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
    Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma.
    Zhang Y; Yang X; Zhu XL; Wang ZZ; Bai H; Zhang JJ; Hao CY; Duan HB
    Front Oncol; 2021; 11():643159. PubMed ID: 33937046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.
    Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.
    Yin L; Xu Y; Yin J; Cheng H; Xiao W; Wu Y; Ji D; Gao S
    Front Mol Neurosci; 2023; 16():1304224. PubMed ID: 38115820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma.
    Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X
    Front Cell Dev Biol; 2021; 9():675555. PubMed ID: 34095147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas.
    Liu Y; Xiang J; Liao Y; Peng G; Shen C
    Front Mol Neurosci; 2022; 15():1037835. PubMed ID: 36407768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
    Gao B; Wang Y; Lu S
    Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Purity as an Underlying Key Factor in Glioma.
    Zhang C; Cheng W; Ren X; Wang Z; Liu X; Li G; Han S; Jiang T; Wu A
    Clin Cancer Res; 2017 Oct; 23(20):6279-6291. PubMed ID: 28754819
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.